Theralink Technologies, Inc. – OTC:OBMP

$1.56

Market closed

Open in about 7 hours

Market Cap	N/A
Enterprise value	8.66B

P/E	-1512.45
EV/Sales	30447.99
EV/EBITDA	-1629.32
Price/Sales	30443.84
Price/Book	-4644.66
PEG ratio	-15.64
EPS	N/A

Revenue	284.67K
EBITDA	-5.31M
Income	-5.95M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-2012.88%
Oper. margin	-2027.93%
Gross margin	67.51%
EBIT margin	-2027.93%
EBITDA margin	-1868.75%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Theralink Technologies, Inc. (OTC:OBMP): Profit margin
Sep 2020	105.33K	-1.34M	-1272.74%
Dec 2020	9.79K	-1.42M	-14591.47%
Sep 2021	90.57K	-1.54M	-1702.89%
Dec 2021	78.97K	-1.64M	-2086.63%

Theralink Technologies, Inc. (OTC:OBMP): Debt to assets
Sep 2020	3196151	1.50M	47.05%
Dec 2020	1945448	1.71M	88.03%
Sep 2021	1638576	3.58M	218.72%
Dec 2021	2746945	4.61M	167.93%

Theralink Technologies, Inc. (OTC:OBMP): Cash Flow
Sep 2020	-1.11M	-35.98K	2M
Dec 2020	-1.14M	-88.21K	0
Sep 2021	-1.08M	-18.65K	1.33M
Dec 2021	-1.49M	0	1.59M

Theralink Technologies alternative data

Theralink Technologies
Employees

Theralink Technologies, Inc. (OTC:OBMP): Employee count
Aug 2023	16
Sep 2023	16
Oct 2023	16
Nov 2023	16
Dec 2023	16
Jan 2024	16
Feb 2024	16
Mar 2024	16
Apr 2024	16
May 2024	16
Jun 2024	16
Jul 2024	16

Theralink Technologies
Insider Trading

Theralink Technologies, Inc. (OTC:OBMP): Insider trades (number of shares)
Period	Buy	Sel
Mar 2015	300000	16950000
Apr 2015	35548272	0
May 2015	35548272	35548272
Sep 2015	0	2050000

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	2 Sep 2015	ELLIOT ROBERT LANGE JR director director	Common stock	1,025,000	$0	$1,025
Sale	2 Sep 2015	HEAD JONATHAN FREDERICK director director	Common stock	1,025,000	$0	$1,025
Purchase	18 May 2015	DIETRICH CONSTANTIN director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	17,774,136	N/A	N/A
Purchase	18 May 2015	DIETRICH CONSTANTIN director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	17,774,136	N/A	N/A
Sale	18 May 2015	LEONE GROUP, LLC 10 percent owner 10 percent owner	Common Stock	17,774,136	N/A	N/A
Sale	18 May 2015	AMERICAN CAPITAL VENTURES, INC. 10 percent owner 10 percent owner	Common Stock	17,774,136	N/A	N/A
Purchase	14 Apr 2015	DIETRICH CONSTANTIN director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	17,774,136	N/A	N/A
Purchase	14 Apr 2015	DIETRICH CONSTANTIN director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	17,774,136	N/A	N/A
Purchase	10 Mar 2015	DIETRICH CONSTANTIN director, officer: Chief Executive Off.. director, officer: Chief Execut..	Common Stock	300,000	N/A	N/A
Sale	10 Mar 2015	CARUSONE JOSEPH director, officer: VP, Investor Relations# director, officer: VP, Investor..	Common Stock	2,100,000	N/A	N/A

OBMP insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Theralink Technologies stock today?

One share of Theralink Technologies stock can currently be purchased for approximately $1.56.
When is Theralink Technologies's next earnings date?

Unfortunately, Theralink Technologies's (OBMP) next earnings date is currently unknown.
Does Theralink Technologies pay dividends?

No, Theralink Technologies does not pay dividends.
What is Theralink Technologies's stock symbol?

Theralink Technologies, Inc. is traded on the OTC under the ticker symbol "OBMP".
What is Theralink Technologies's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Theralink Technologies?

Shares of Theralink Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Theralink Technologies have?

As Jul 2024, Theralink Technologies employs 16 workers.
When Theralink Technologies went public?

Theralink Technologies, Inc. is publicly traded company for more then 3 years since IPO on 5 Oct 2021.
What is Theralink Technologies's official website?

The official website for Theralink Technologies is theralink.com.
Where are Theralink Technologies's headquarters?

Theralink Technologies is headquartered at 15000 West 6th Avenue, Golden, CO.
How can i contact Theralink Technologies?

Theralink Technologies's mailing address is 15000 West 6th Avenue, Golden, CO and company can be reached via phone at +7 204200074.

Theralink Technologies, Inc.

theralink.com

Exchange:

OTC

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of novel cancer immunotherapy products. The company through its patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. The company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. Theralink Technologies, Inc. was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. The company is headquartered in Golden, Colorado.

+7 204200074

15000 West 6th Avenue
Golden, CO 80401

CIK: 0001362703
ISIN: US68235A2006
CUSIP: 68235A200